Back

Prediction of cardiac ATTR depletion by ALXN2220 using mechanistic PK/PD modeling

13 May 2024 (15:51 - 17:00)
Organised by: Logo
Congress Presentation Part of: ePosters in basic science 3 Heart Failure HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Peter Christian Kahr

Neurimmune, Schlieren (Switzerland)

6 More presentations in this session

Presentation thumbnail
Risk of acute kidney injury and death in patients with acute decompensated heart failure in the intensive care unit
Doctor R. Andriamanohery (Antananarivo, MG)
Abstract Slides Video
Presentation thumbnail
Study of the contribution of neurotrophin genetic variation in heart failure
Doctor M. Bicho (Lisboa, PT)
Abstract Slides Video
Presentation thumbnail
Exploring pathophysiological changes in Takotsubo syndrome through histology and troponin release in a small-animal model
Mr E. Zulfaj (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Different blood proteomic profile in patients with heart failure according to the presence of iron deficiency
Doctor J. Comin-Colet (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Beyond the fire sparks: platelets and neutrophils as warriors and silent alarms for high Killip class after acute myocardial infarction
Doctor J. Cosmina (Bucharest, RO)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in basic science 3

The Event

Event poster

Heart Failure 2024

13 May 2024 15:51 CET
You may be interested in
thumbnail
Congress Presentation
Initial safety of targeted immune activation with the amyloid depleter ALXN2220
thumbnail
Congress Presentation
Tolerability of continued treatment with ATTR depleter ALXN2220 in the open-label extension of Phase 1 study NI006-101
thumbnail
Congress Presentation
Long-term safety and efficacy of antibody ALXN2220 for depletion of cardiac amyloid transthyretin: results of treatment beyond 12 months in the open-label extension of study NI006-101

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources